Rhabdomyolysis: a rare adverse effect of levetiracetam

A 62-year-old previously healthy male was admitted with new onset generalised tonic-clonic seizures. Treatment was initiated with the antiepileptic levetiracetam and he had no further episodes of seizures. Creatine kinase (CPK) level was 1812 IU/L 12-hour postadmission. Despite good hydration, his C...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Case Rep
Asıl Yazarlar: Thomas, Liza, Mirza, Madiha Muhammed Farooq, Shaikh, Niaz Ahmed, Ahmed, Nahla
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720964/
https://ncbi.nlm.nih.gov/pubmed/31451475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230851
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller